NOVAVAX INC — DEF 14A

NOVAVAX INC of GAITHERSBURG, MD filed a DEF 14A with the SEC on 2025-04-29. Industry: Biological Products, (No Diagnostic Substances).

Filing

Documents (100)

Showing 15 of 100 documents.

SeqTypeDescription
1DEF 14ADEF 14A
2EX-101.SCHXBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
3EX-101.DEFXBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
4EX-101.LABXBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
5EX-101.PREXBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
6GRAPHICnvax-20250429_g1.jpg
7GRAPHICnvax-20250429_g10.jpg
8GRAPHICnvax-20250429_g100.jpg
9GRAPHICnvax-20250429_g101.jpg
10GRAPHICnvax-20250429_g102.jpg
11GRAPHICnvax-20250429_g103.jpg
12GRAPHICnvax-20250429_g104.jpg
13GRAPHICnvax-20250429_g105.jpg
14GRAPHICnvax-20250429_g106.jpg
15GRAPHICnvax-20250429_g107.jpg

Filing timeline for this registrant (60)

Showing 12 of 60 filings.

FiledForm
2026-04-27DEFA14A
2026-04-27DEF 14A
2025-04-30DEFA14A
2025-04-29DEF 14A
2024-06-05DEFA14A
2024-05-20DFAN14A
2024-05-13DFAN14A
2024-05-08DFAN14A
2024-05-07DFAN14A
2024-05-06PREC14A
2024-05-06DFAN14A
2024-04-29DEFA14A

More